Show Summary Details
Page of

Parvovirus 

Parvovirus
Chapter:
Parvovirus
DOI:
10.1093/med/9780198729228.003.0097
Page of

PRINTED FROM OXFORD MEDICINE ONLINE (www.oxfordmedicine.com). © Oxford University Press, 2016. All Rights Reserved. Under the terms of the licence agreement, an individual user may print out a PDF of a single chapter of a title in Oxford Medicine Online for personal use (for details see Privacy Policy and Legal Notice).

date: 26 June 2019

Parvovirus B19 infection usually has a benign course in children. It is highly infectious and most commonly causes erythema infectiosum (slapped cheek syndrome, fifth disease), a mild exanthematous disease of early childhood associated with a characteristic facial rash. A more severe course with associated complications may arise in individuals with haemolytic disease, immunocompromised patients, and pregnant women. There is no specific antiviral treatment or vaccine available. A novel parvovirus human parvovirus 4 was identified in 2005, but its clinical correlates are uncertain.

Access to the complete content on Oxford Medicine Online requires a subscription or purchase. Public users are able to search the site and view the abstracts for each book and chapter without a subscription.

Please subscribe or login to access full text content.

If you have purchased a print title that contains an access token, please see the token for information about how to register your code.

For questions on access or troubleshooting, please check our FAQs, and if you can't find the answer there, please contact us.